reports
Tenaya Therapeutics Presents Interim Data from RIDGE™ Natural History ...
Tenaya Therapeutics Presents Interim Data from RIDGE™ Natural History and Seroprevalence Study of Adults with PKP2-associated ARVC at Heart Rhythm 2025 RIDGE is Largest Natural History Study Conducted with More Than 175 Participants Enrolled to Date with Arrhythmogenic Right Ventricular Cardiomyopathy Due to Mutations in the PKP2 Gene Patients Experience High Burden of Arrhythmias and Severe Disease Progression Despite Standard-of-Care Treatments Large Majority of PKP2-associated ARVC Patients Appear Eligible for TN-401 Gene Therapy Based on Low Rates of Preexisting Immunity to AAV9 Antib...
RBB Bancorp Declares Quarterly Cash Dividend of $0.16 Per Common Share
RBB Bancorp Declares Quarterly Cash Dividend of $0.16 Per Common Share LOS ANGELES, April 17, 2025 (GLOBE NEWSWIRE) -- RBB Bancorp (NASDAQ: ) and its subsidiaries, Royal Business Bank ("the Bank") and RBB Asset Management Company ("RAM"), collectively referred to herein as "the Company", announced that its Board of Directors has declared a quarterly cash dividend of $0.16 per common share. The dividend is payable on May 12, 2025 to common shareholders of record as of April 30, 2025. Corporate Overview RBB Bancorp is a bank holding company headquartered in Los Angeles, California. As of ...
RBB Bancorp to Report First Quarter 2025 Financial Results
RBB Bancorp to Report First Quarter 2025 Financial Results LOS ANGELES, April 07, 2025 (GLOBE NEWSWIRE) -- RBB Bancorp (NASDAQ: ) and its subsidiaries, Royal Business Bank (the "Bank") and RBB Asset Management Company ("RAM"), collectively referred to herein as the "Company", today announced that it will release financial results for its first quarter ended March 31, 2025 after the markets close on Monday, April 28, 2025. Management will hold a conference call at 11:00 a.m. Pacific Time/2:00 p.m. Eastern Time on Tuesday, April 29, 2025 to discuss the Company's financial results. To list...
PennantPark Investment Corporation Schedules Earnings Release of Secon...
PennantPark Investment Corporation Schedules Earnings Release of Second Fiscal Quarter 2025 Results MIAMI, April 03, 2025 (GLOBE NEWSWIRE) -- PennantPark Investment Corporation (the "Company") (NYSE: PNNT) announced that it will report results for the second fiscal quarter ended March 31, 2025 on Monday, May 12, 2025 after the close of the financial markets. The Company will also host a conference call at 12:00 p.m. (Eastern Time) on Tuesday, May 13, 2025 to discuss its financial results. All interested parties are welcome to participate. You can access the conference call by dialing tol...
PennantPark Investment Corporation Announces Monthly Distribution of $...
PennantPark Investment Corporation Announces Monthly Distribution of $0.08 per Share MIAMI, April 02, 2025 (GLOBE NEWSWIRE) -- PennantPark Investment Corporation (the "Company") (NYSE: PNNT) declares its monthly distribution for April 2025 of $0.08 per share, payable on May 1, 2025 to stockholders of record as of April 15, 2025. The distribution is expected to be paid from taxable net investment income. The final specific tax characteristics of the distribution will be reported to stockholders on Form 1099 after the end of the calendar year and in the Company's periodic report filed with ...
Tenaya Therapeutics Announces Late Breaker Presentation of New Data fr...
Tenaya Therapeutics Announces Late Breaker Presentation of New Data from MyPEAK™-1 Phase 1b/2 Clinical Trial of TN-201 at American College of Cardiology Annual Meeting TN-201 Has Been Well Tolerated at 3E13 vg/kg Dose New Biopsy Data Reaffirm Robust Transduction and RNA Expression with TN-201; RNA and Protein Levels Increase Over Time All Cohort 1 Patients with Severe Disease at Baseline Achieved NYHA Class I Two of Three Patients Experienced Improvements in One or More Measures of Hypertrophy Expects to Complete Enrollment of Cohort 2 in 1H25 and to Report Initial Data in 2H25 ...
- Jonathan Chaplin
Four killer insights from day one
We just wrapped up day one the Future-of-Connectivity conference that we host every year with BCG. We gleaned new insights into the risk of the broadband market getting more competitive, wireless market growth, what is driving the convergence imperative, and Lumen’s appetite for asset sales.
- Jonathan Chaplin
- Jonathan Chaplin
AT&T in talks to buy Lumen fiber assets
Bloomberg reports that AT&T is in exclusive discussions to buy the fiber business for “more than $5.5BN”. We are not at all surprised that the deal is happening or that AT&T is the buyer. We are surprised by the price – it looks too low. Our quick thoughts in this brief note.
Tenaya Therapeutics Publishes Preclinical Data Demonstrating TN-201 En...
Tenaya Therapeutics Publishes Preclinical Data Demonstrating TN-201 Enhances Cardiac Function and Survival in MYBPC3 Cardiomyopathy Models Robust Evidence of Disease Reversal in Severe Knock Out Mice Model Supports Tenaya’s Clinical Development Plan to Evaluate TN-201 as a Potential Treatment for Patients with MYBPC3-associated Hypertrophic Cardiomyopathy SOUTH SAN FRANCISCO, Calif., March 24, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (Nasdaq: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that addres...
NGL Energy Partners LP Announces Quarterly Cash Distribution for the C...
TULSA, Okla.--(BUSINESS WIRE)-- NGL Energy Partners LP (NYSE: NGL) announced today that the Board of Directors of its general partner declared a distribution for the quarter ending March 31, 2025 to be paid to the holders of the Partnership’s 11.803% Class B Floating Rate Cumulative Redeemable Perpetual Preferred Units (“Class B Preferred Units”) and the 11.713% Class C Floating Rate Cumulative Redeemable Perpetual Preferred Units (“Class C Preferred Units”) in accordance with the terms outlined in NGL’s partnership agreement. Each of the Class B Preferred Units will receive a quarterly distri...
Tenaya Therapeutics Announces Late Breaker and New Data Presentations ...
Tenaya Therapeutics Announces Late Breaker and New Data Presentations at the American College of Cardiology’s Annual Scientific Session Late Breaker Oral Presentation to Include New Data from Cohort 1 of the MyPEAK™-1 Phase 1b/2 Clinical Trial of TN-201 SOUTH SAN FRANCISCO, Calif., March 19, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today announced that new clinical and disease burden data pert...
- Jonathan Moreland
GPN GLOBAL PAYMENTS INC.
MGPI MGP INGREDIENTS INC.
KRO KRONOS WORLDWIDE INC.
I3N CHART INDUSTRIES INC.
FRPT FRESHPET INC
CRMT AMERICA'S CAR-MART INC.
BUSE FIRST BUSEY CORPORATION
ASYS AMTECH SYSTEMS INC.
AAP ADVANCE AUTO PARTS INC.
CULP CULP INC.
KYN KAYNE ANDERSON MLP INVESTMENT CO.
FLWS 1-800-FLOWERS.COM CL A
FCNCA FIRST CITIZENS BANCSHARES INC. CLASS A
NFE NEW FORTRESS ENERGY
AMPY AMPLIFY ENERGY
RC GRUPO RADIO CENTRO S.A.B. DE C.V.
AWRE AWARE INC.
PFBX PEOPLES FINANCIAL CORP. (MISSISSIPPI)
VSCO VICTORIA'S SECRET & CO
ECAT BLACKROCK ESG CAP ALLOCATION TR
SBGI SINCLAIR INC
CVI CVR ENERGY
SRBK INC.
CUBA SR BANCORP INC
BHRB THE HERZFELD CARIBBEAN BASIN FUND
SUNS INC.
VG BURKE HERBERT FINANCIAL SERVICES CORP
SUNRISE REALTY TRUST
VENTURE GLOBAL INC.
Tenaya Therapeutics Reports Fourth Quarter and Full Year 2024 Financia...
Tenaya Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update Dosing Initiated in Cohort 2 of the MyPEAK™-1 Phase 1b/2 Clinical Trial of TN-201 for Treatment of MYBPC3-Associated Hypertrophic Cardiomyopathy MyPEAK-1 Cohort 1 Data Accepted for Late-Breaker Presentation at the American College of Cardiology Meeting Initial Data from RIDGE™-1 Phase 1b Clinical Trial of TN-401 for PKP2-Associated Arrhythmogenic Right Ventricular Cardiomyopathy Expected in 2H25 Recent $48.9 Million Financing Extends Cash Runway into mid-2026 SOUTH SAN FR...
- Jonathan Chaplin
The Lumen transaction report series
The biggest transaction likely to happen this year will be the sale of all or part of Lumen’s Mass Markets business (we expect other much bigger deals, but these will likely take longer to emerge than some seem to expect). We have covered the potential Lumen transaction in three reports in the last week: 1. We explored the Mass Markets asset in a detailed report last week that leverages Broadband Insights. This covered the markets where Lumen has deployed fiber so far, the number of competitor...
- Jonathan Moreland
PEB PEBBLEBROOK HOTEL TRUST
PBF PBF ENERGY INC. CLASS A
MTDR MATADOR RESOURCES COMPANY
MPC MARATHON PETROLEUM CORPORATION
LTRX LANTRONIX INC.
FRPT FRESHPET INC
EIX EDISON INTERNATIONAL
DRTTF DIRTT ENVIRONMENTAL SOLUTIONS
CMCO COLUMBUS MCKINNON CORPORATION
FLWS 1-800-FLOWERS.COM CL A
JELD JELD-WEN HOLDING INC.
FRAF FRANKLIN FINANCIAL SERVICES CO.
ELAN ELANCO ANIMAL HEALTH INC.
ABCL ABCELLERA BIOLOGICS
PFBX PEOPLES FINANCIAL CORP. (MISSISSIPPI)
JANX JANUX THERAPEUTICS INC
TNYA TENAYA THERAPEUTICS INC
IE IVANHOE ELECTRIC INC
ECAT BLACKROCK ESG CAP ALLOCATION TR
ELTX ANGION BIOMEDICA CORP
CVI CVR ENERGY
GAM INC.
GENERAL DE ALQUILER DE MAQUINARIA
- Jonathan Chaplin
LUMN: a closer look at the infrastructure for sale
We published a report earlier this week arguing that the three national wireless carriers should all be targeting Lumen’s Mass Markets assets. In this follow-up, we provide a breakdown of Lumen’s Mass Markets assets, detailing where fiber has been deployed, how many copper locations can be upgraded with good returns, and who they compete against in fiber markets, upgradeable copper markets, and residual copper markets.
- Jonathan Moreland
PEB PEBBLEBROOK HOTEL TRUST
MTDR MATADOR RESOURCES COMPANY
JCOM J2 GLOBAL INC.
IFF INTERNATIONAL FLAVORS & FRAGRANCES INC.
HUN HUNTSMAN CORPORATION
FTAI FORTRESS TRANSPORTATION AND INFRASTRUCTURE INVESTORS LLC
ETSY ETSY INC.
ECPG ENCORE CAPITAL GROUP INC.
DAKT DAKTRONICS INC.
ASYS AMTECH SYSTEMS INC.
ARCC ARES CAPITAL CORPORATION
CMCO COLUMBUS MCKINNON CORPORATION
FMC FMC CORPORATION
MAC MACERICH COMPANY
WVE WAVE LIFE SCIENCES
PLBC PLUMAS BANCORP
FBK FB FINANCIAL CORPORATION
CWH CAMPING WORLD HOLDINGS INC. CLASS A
FLGT FULGENT GENETICS
PK PARK HOTELS & RESORTS INC.
FTDR FRONTDOOR INC.
AX AXOS FINANCIAL INC.
STRA STRATEGIC EDUCATION INC.
LBSRD LIBERTY STAR URANIUM & METALS
BCDA BIOCARDIA
ALEC ALECTOR
AMCR AMCOR PLC
RVLV REVOLVE GROUP
GO GROCERY OUTLET HOLDING
NOG NORTHERN OIL AND GAS
UAN CVR PARTNERS LP
PFX PHENIXFIN CORP
CLVT CLARIVATE PLC
KIND NEXTDOOR HLDGS INC
BHVN BIOHAVEN LTD
BHRB BURKE & HERBERT BANK & TR/VA
MAIA MAIA BIOTECHNOLOGY INC
AMWL AMERICAN WELL CORP
- Jonathan Chaplin
PennantPark Investment Corporation Announces Monthly Distribution of $...
PennantPark Investment Corporation Announces Monthly Distribution of $0.08 per Share MIAMI, March 04, 2025 (GLOBE NEWSWIRE) -- PennantPark Investment Corporation (the "Company") (NYSE: PNNT) declares its monthly distribution for March 2025 of $0.08 per share, payable on April 1, 2025 to stockholders of record as of March 14, 2025. The distribution is expected to be paid from taxable net investment income. The final specific tax characteristics of the distribution will be reported to stockholders on Form 1099 after the end of the calendar year and in the Company's periodic report filed wit...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.